Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Strategic Partnership

10 Jun 2013 07:00

RNS Number : 6083G
Ideagen PLC
10 June 2013
 



 

Ideagen plc

("Ideagen" or the "Company")

 

Strategic Partnership with a Leading Global Medical Device Manufacturer

 

Ideagen PLC (AIM: IDEA), a leading supplier of Compliance based Information Management solutions is pleased to announce that it has signed a strategic partnership with a leading global manufacturer of medical devices to supply the company's order communications software, dartOCM, into the UK NHS.

 

DartOCM is an application platform which provides context related intelligent information management of pathology services for both hospitals and GP clinicians. The solution enables the ordering of appropriate tests while delivering "paperless" results back to the clinician with real time notifications and alerts in a centralised patient record.

 

The UK NHS is currently undergoing a consolidation of its pathology services in line with the Carter report (2008), which stated that reform was key and could deliver £500m savings annually whilst improving service levels. "Consolidation of pathology services into reconfigured networks will improve services for patients by enhancing value for money and releasing resources for investment to improve service quality and patient safety". To date 2 regional networks have been announced with additional regions expected to be announced over the next year.

 

The partnership has resulted in an immediate £150k contract to supply the dartOCM system to an Acute Trust in the Midlands, which will be used as a 'lighthouse' pilot to demonstrate the compelling value proposition of the solution in terms of both operational and financial benefits. It is expected that, if successful, the planned regional roll out will generate a significant, multi-year contract for Ideagen supporting 10,000 users across 700 sites, and provide a strong reference to accelerate further roll-outs in to new networks across the country.

 

David Hornsby Chief Executive said: ''I am delighted that we have been selected to support this important programme for the NHS. There is a significant market opportunity to provide dartOCM to streamline the test and results process in supporting the consolidation of pathology services within the NHS. To be selected as the preferred technology platform by a global leader in the field of medical diagnostic equipment is a testament to our prominent position in this area''

Enquiries:

Ideagen Plc

Tel: 01629 761590

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap (Nominated Adviser and Broker)

Tel: 020 7220 0500

Matt Goode/ Charlotte Stranner (Corporate Finance)

Stephen Norcross (Corporate Broking)

Walbrook PR Ltd

Tel: 020 7933 8780

Helen Westaway

Helen.westaway@walbrookpr.com

Paul Cornelius

Paul.cornelius@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKODQPBKDBAK
Date   Source Headline
14th Oct 20215:46 pmRNSIssue of new shares under the SIP
14th Oct 20217:00 amRNSSale of Pentana Compliance
11th Oct 20212:25 pmRNSNotice of AGM
1st Oct 20213:15 pmRNSTotal Voting Rights
1st Oct 20217:00 amRNSChange of Auditor
24th Sep 20219:37 amRNSIssue of Shares, PDMR Dealing & TVR
13th Sep 20214:50 pmRNSExercise of Options and Total Voting Rights
10th Sep 20216:05 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSTotal Voting Rights
31st Aug 20219:32 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSPDMR Dealing and Total Voting Rights
11th Aug 20212:02 pmRNSIssue of new shares under the SIP and TVR
11th Aug 20217:00 amRNSExercise of Options and Total Voting Rights
23rd Jul 20214:54 pmRNSPDMR Dealing and Total Voting Rights
22nd Jul 20217:00 amRNSFinal Results
20th Jul 20212:03 pmRNSIssue of new shares under the SIP
19th Jul 20217:00 amRNSTwo highly complementary strategic acquisitions
15th Jul 20214:17 pmRNSExercise of share options and Total Voting Rights
16th Jun 20217:00 amRNSIssue of new shares under the SIP
10th Jun 20214:41 pmRNSSecond Price Monitoring Extn
10th Jun 20214:36 pmRNSPrice Monitoring Extension
21st May 20217:00 amRNSDirector/PDMR Shareholding
13th May 20217:00 amRNSPre-Close Trading Update and Board Change
28th Apr 20217:00 amRNSDirector Dealings and Total Voting Rights
14th Apr 202112:40 pmRNSIssue of Shares, PDMR Dealing & TVR
16th Mar 20213:33 pmRNSIssue of new shares under the SIP and TVR
9th Mar 20217:00 amRNSAcquisition of Qualtrax
26th Feb 20211:49 pmRNSHolding(s) in Company
25th Feb 20214:00 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSHolding(s) in Company
23rd Feb 20217:00 amRNSPDMR Dealing and Total Voting Rights
16th Feb 20215:15 pmRNSIssue of Equity & Total Voting Rights
12th Feb 20217:00 amRNSDirector/PDMR Dealings
3rd Feb 20219:35 amRNSExtension to 2018 LTIP Awards
26th Jan 20217:00 amRNSSuccession of Chairman
26th Jan 20217:00 amRNSUnaudited Interim Results
25th Jan 20214:26 pmRNSH1 Results Presentation
22nd Jan 20217:00 amRNSHolding(s) in Company
31st Dec 20207:00 amRNSHolding(s) in Company
31st Dec 20207:00 amRNSHolding(s) in Company
30th Dec 20207:21 amRNSCompletion of Huddle Acquisition
23rd Dec 202011:30 amRNSAcquisition of Huddle
22nd Dec 20202:04 pmRNSHolding(s) in Company
18th Dec 202012:56 pmRNSIssue of Shares & Director/PDMR Shareholding
9th Dec 20207:00 amRNSResult of Placing and PrimaryBid Offer
8th Dec 20204:53 pmRNSPrimaryBid.com Offer
8th Dec 20204:50 pmRNSProposed Fundraise of £48.7 million
20th Nov 20203:40 pmRNSIssue of Equity, PDMR Dealing and TVR
17th Nov 202012:05 pmRNSChange of Registered Office
13th Nov 20203:51 pmRNSPDMR Shareholding and Exercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.